Impressive thrombocytosis evolving in a patient with a BCR-ABL positive CML in major molecular response during dasatinib treatment unmasks an additional JAK2V617F.
2013/1/1
Medizin - Open Access LMU - Teil 21/22
Frequently requested episodes will be transcribed first
Shownotes Transcript
No transcript made for this episode yet, you may request it for free.